CD80 and neoplasm: Indeed, Raji tumors with CD80/86/70 deletion also rejected in HIS-reconstituted mice (Supplementary Fig. 4d), indicating that other factors may contribute to the ability of Raji tumors to elicit tumor-specific T-cell responses in vivo.